Research
Scientists turn protein-making errors in cancer cells into a targeted kill switch
The Brief
- Cancer cells produce their own proteins during survival, as all cells do.
- During protein production, cells sometimes encounter a glitch called ribosomal frameshifting.
- The source describes this event as exceptionally rare, occurring roughly once in every 100,000 instances; the excerpt is cut off there.
Why it matters
The work proposes using errors in cancer cells' protein production as a targeted way to kill them, a possible route for therapies that act on a specific cellular fault.
Who’s affected
- cancer researchers and biologists
- drug developers working on targeted cancer therapies
- #cancer
- #ribosomal-frameshifting
- #protein-synthesis
- #targeted-therapy
- #cell-biology
Like every other cell in the human body, cancer cells also produce their own share of proteins for survival. During this production process, cells often encounter a glitch called ribosomal frameshifting. This exceptionally rare event occurs roughly once in every 100,000…
Timeline
Research on using protein-making errors as a kill switch reported by Medical Xpress
Medical Xpress - latest medical and health news stories
Scientists turn protein-making errors in cancer cells into a targeted kill switch